Since concomitant KRAS and BRAF tumor mutations are considered mutually exclusive we wanted to confirm that the CRC cases carrying KRAS mutation show negative BRAF V600E staining by IHC with anti-BRAF V600E (VE1) antibody. The gene discussed is BRAF; the disease is neoplasm.